EC ever use among women of reproductive age: 0.3% (DHS 2007, among ever married women)*
EC knowledge among women of reproductive age: 11% (DHS 2012)
Contraceptive Use: 80.4% (DHS 2007, ever use of a modern method among ever married women)
Registered LNG-EC products:
- Postinor-2* - Available only with prescription
Registered UPA-EC products:
- ellaOne* - Available only with prescription
Products marked with * have been approved by a stringent regulatory authority, such as the WHO Prequalification Programme, the US Food and Drug Administration, the European Medicines Agency, or other.
Where at least one type of ECP is available: Pharmacies, IPPF-affiliated system, Social marketing programs (eg PSI, DKT, MSI and PSIA)
Age restrictions for accessing ECPs: No data available
Legal/regulatory documents in which EC is included: No data available
Other relevant information: Indonesia's 2008 Essential Medicines List does not include EC.
*Ever Use of EC was not reported on in the 2012 DHS.
EC distributed via IPPF outlets (<500 in 2012).
In Indonesia, the lowest cadre of health workers allowed to sell/dispense ECPs in the private sector is midwives, as of 2013. (USAID/DELIVER, Contraceptive Security Indicators, 2013)
In 2013, EC was not procured by the government (JSI/Deliver data).
For more information, see below: